Delivery Order SPE2DB24D2101-SPE2DB25FKMNR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Enhertu 100 mg vials, a specialty pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $10,666.20, is set to be completed by August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive delivery order issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of 100 mg vials of Enhertu, a prescription oncology medication, with a ceiling value of $7,110.80. This firm fixed-price contract, which is not set-aside, has an ultimate completion date of August 18, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- This delivery order, valued at $17,777, was awarded on July 22, 2025, to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials under a firm fixed-price arrangement. The contract is a non-set-aside award issued by the Medical Supply Chain, a Defense-focused federal agency, with a completion deadline of August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $17,777 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a HER2-directed antibody-drug conjugate used in oncology treatment. This non-set-aside competitive award, issued on July 25, 2025, is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,733.08 Firm Fixed Price Delivery Order is for the supply of ENHERTU 100 MG vials, a specialty oncology medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 mg vials. The $26,932.32 firm fixed-price contract has an ultimate completion date of January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $13,016.24 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4566023708 ENHERTU 100 MG VIALS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a range of medical commodities to military treatment programs and facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,894.24 firm-fixed-price delivery order is for the supply of ENHERTU 100 MG vials, a specialty pharmaceutical product. The contract has an ultimate completion date of July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a $25,248.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENHERTU 100 MG VIALS. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMNRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, valued at $8,888.50 with a firm fixed price arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor headquartered in Pennsylvania that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a registered System for Award Management vendor, the company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Enhertu—a specialty oncology medication—exemplifies the company's role in supporting military healthcare programs through the comprehensive pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 7/21/25 |